• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区生存时间超过 5 年的口腔癌患者的临床结局。

Clinical outcomes of oral cancer patients who survive for more than 5 years in Taiwan.

机构信息

Department of Dentistry, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Department of Dentistry, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.

出版信息

J Formos Med Assoc. 2019 Dec;118(12):1616-1622. doi: 10.1016/j.jfma.2019.07.022. Epub 2019 Aug 1.

DOI:10.1016/j.jfma.2019.07.022
PMID:31377113
Abstract

BACKGROUND/PURPOSE: Oral cancer patients who survive for more than 5 years are supposed to have a reduced local cancer recurrence rate and survive longer. This study evaluated whether oral cancer patients who survived for more than 5 years might have reduced rates of local cancer recurrence, development of the second or third primary oral cancer, or the late regional cervical lymph node metastasis.

METHODS

This study analyzed the clinical outcomes of 127 oral cancer patients (101 men and 26 women; mean age, 50.8 ± 12.1 years) who survived for more than 5 years after proper treatments of the initial primary oral cancers.

RESULTS

The 127 primary oral cancers included 117 squamous cell carcinomas (SCCs), 7 mucoepidermoid carcinomas, and 3 others. Of the 127 oral cancer patients who survived for more than 5 years, 47 survived for 5-9 years, 45 for 10-14 years, 22 for 15-19 years, 10 for 20-24 years, two for 25-29 years, and one for 30 years. Ten patients had local cancer recurrence 5.4 years-13.7 years, 12 patients had a second or a third primary oral cancer 3.6 years-17.2 years, and one mucoepidermoid carcinoma patient had a late regional cervical lymph node metastasis 11.9 years after total excision of the initial primary oral cancers.

CONCLUSION

Oral cancer patients who survive for more than 5 years may still have local cancer recurrence, the second or third primary oral cancer, or the late regional cervical lymph node metastasis but with a reduced rate.

摘要

背景/目的:存活时间超过 5 年的口腔癌患者局部癌症复发率较低,且存活时间更长。本研究评估了存活时间超过 5 年的口腔癌患者是否具有降低局部癌症复发率、发展第二或第三原发口腔癌或晚期区域性颈淋巴结转移的风险。

方法

本研究分析了 127 例(101 名男性和 26 名女性;平均年龄 50.8±12.1 岁)经适当治疗后存活时间超过 5 年的初始原发性口腔癌患者的临床结果。

结果

127 例原发性口腔癌包括 117 例鳞状细胞癌(SCC)、7 例黏液表皮样癌和 3 例其他类型。127 例存活时间超过 5 年的口腔癌患者中,47 例存活 5-9 年,45 例存活 10-14 年,22 例存活 15-19 年,10 例存活 20-24 年,2 例存活 25-29 年,1 例存活 30 年。10 例患者在 5.4 年-13.7 年内出现局部癌症复发,12 例患者在 3.6 年-17.2 年内出现第二或第三原发口腔癌,1 例黏液表皮样癌患者在完全切除初始原发性口腔癌 11.9 年后出现晚期区域性颈淋巴结转移。

结论

存活时间超过 5 年的口腔癌患者仍可能出现局部癌症复发、第二或第三原发口腔癌或晚期区域性颈淋巴结转移,但复发率较低。

相似文献

1
Clinical outcomes of oral cancer patients who survive for more than 5 years in Taiwan.台湾地区生存时间超过 5 年的口腔癌患者的临床结局。
J Formos Med Assoc. 2019 Dec;118(12):1616-1622. doi: 10.1016/j.jfma.2019.07.022. Epub 2019 Aug 1.
2
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
3
Cervical lymph node metastasis after local excision of early squamous cell carcinoma of the oral cavity.口腔早期鳞状细胞癌局部切除术后的颈部淋巴结转移
Am J Surg. 1986 Oct;152(4):361-6. doi: 10.1016/0002-9610(86)90305-3.
4
Survival, metastasis and recurrence of oral cancer in relation to pathological features.口腔癌的生存、转移及复发与病理特征的关系
Ann R Coll Surg Engl. 1995 Sep;77(5):325-31.
5
A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.第二原发性恶性肿瘤是淋巴结未受累的胸段食管鳞状细胞癌患者的主要死亡原因。
J Am Coll Surg. 2005 Aug;201(2):188-93. doi: 10.1016/j.jamcollsurg.2005.03.013.
6
Oral maxillary squamous carcinoma: an indication for neck dissection in the clinically negative neck.口腔上颌鳞状细胞癌:临床阴性颈部行颈清扫术的适应证。
Head Neck. 2011 Nov;33(11):1581-5. doi: 10.1002/hed.21631. Epub 2010 Dec 6.
7
Outcome of local failures after oral cancer - recurrence vs. second primary.口腔癌局部治疗失败的结果——复发与第二原发肿瘤。
J Oral Pathol Med. 2010 Oct;39(9):657-61. doi: 10.1111/j.1600-0714.2010.00905.x. Epub 2010 Jul 2.
8
Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.口腔上皮发育异常引发的口腔鳞状细胞癌的转归:在多学科诊所监测口腔癌前病变的理论依据
Br J Oral Maxillofac Surg. 2013 Oct;51(7):594-9. doi: 10.1016/j.bjoms.2013.03.014. Epub 2013 Apr 16.
9
Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.内皮糖蛋白的表达与口腔和口咽癌不良的肿瘤学预后相关。
Acta Otolaryngol. 2006 Jun;126(6):633-9. doi: 10.1080/00016480500452558.
10
Perineural invasion as a major determinant for the aggressiveness associated with increased tumor thickness in t1-2 oral tongue and buccal squamous cell carcinoma.神经周围侵犯是导致 T1-2 期口腔舌和颊部鳞状细胞癌肿瘤厚度增加相关侵袭性行为的主要决定因素。
Ann Surg Oncol. 2013 Oct;20(11):3568-74. doi: 10.1245/s10434-013-3068-5. Epub 2013 Jul 10.

引用本文的文献

1
Protein inhibitor of activated signal transducer and activator of transcription 2 is an oncoprotein in oral squamous cell carcinoma and related to cigarette smoking - An in vitro study.活化信号转导子和转录激活子2的蛋白抑制剂是口腔鳞状细胞癌中的一种癌蛋白且与吸烟相关——一项体外研究
J Dent Sci. 2024 Oct;19(4):1983-1990. doi: 10.1016/j.jds.2024.07.013. Epub 2024 Jul 20.
2
Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC).口腔黏膜下纤维化(OSMF)和口腔鳞状细胞癌(OSCC)患者中hsa miR - 101 - 5p和hsa miR - 155 - 3p表达与c - Fos的相关性
J Maxillofac Oral Surg. 2023 Jun;22(2):381-387. doi: 10.1007/s12663-021-01668-0. Epub 2021 Nov 27.
3
Orbital Apex Syndrome: A Case Series in a Tertiary Medical Center in Southern Taiwan.眶尖综合征:台湾南部一家三级医疗中心的病例系列
Front Med (Lausanne). 2022 Mar 8;9:845411. doi: 10.3389/fmed.2022.845411. eCollection 2022.
4
Outpatient Dental Treatment Expenditure for Patients with Oromaxillofacial Cancer: A Cohort Study in Taiwan.台湾口颜面癌病患之门诊牙科处置费用:群组研究。
Int J Environ Res Public Health. 2022 Jan 19;19(3):1066. doi: 10.3390/ijerph19031066.
5
Identification of Prognostic Biomarkers Originating From the Tumor Stroma of Betel Quid-Associated Oral Cancer Tissues.槟榔相关口腔癌组织肿瘤基质来源的预后生物标志物的鉴定
Front Oncol. 2021 Nov 16;11:769665. doi: 10.3389/fonc.2021.769665. eCollection 2021.
6
Developing an Algorithm for Discriminating Oral Cancerous and Normal Tissues Using Raman Spectroscopy.利用拉曼光谱法开发一种区分口腔癌组织和正常组织的算法。
J Pers Med. 2021 Nov 9;11(11):1165. doi: 10.3390/jpm11111165.
7
Dysregulation of the miR-30a/BiP axis by cigarette smoking accelerates oral cancer progression.吸烟导致的miR-30a/BiP轴失调会加速口腔癌进展。
Cancer Cell Int. 2021 Oct 30;21(1):578. doi: 10.1186/s12935-021-02276-1.
8
Prognostic Factors Associated with Successful Salvage Surgery in Recurrent Oral Cancer.复发性口腔癌挽救性手术成功的相关预后因素
Diagnostics (Basel). 2021 Jun 17;11(6):1105. doi: 10.3390/diagnostics11061105.
9
Ginsenoside M1 Induces Apoptosis and Inhibits the Migration of Human Oral Cancer Cells.人参皂苷 M1 诱导人口腔癌细胞凋亡并抑制其迁移。
Int J Mol Sci. 2020 Dec 19;21(24):9704. doi: 10.3390/ijms21249704.